 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression PR Newswire SAN DIEGO, July 28...

First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression

---
- 'Has initiated pilot scale-up of its biosynthetic formulation of psilocybin Developing
  a bacterial biosynthesis process for tryptamine production Well capitalized in an
  oversubscribed raise What PsyBio Therapeutics does: PsyBio Therapeutics Corp (CVE:PSYB)
  is a biotechnology company developing a ...'


PsyBio is developing psychoactive compounds which could be a mental health game changer

---
- Willow Biosciences Inc (TSX:WLLW) (OTCQX:CANSF) (FRA:3D7) ended its third quarter
  with nearly C$9.1 million in cash after completing  a successful pilot run of high-purity
  cannabigerol, or CBG.  The bioscience firm became the first company to produce significant
  amounts of the cannabinoid ...


Willow Biosciences ends 3Q with C$9.1M in cash after successful pilot production of CBG

---
- Willow Biosciences Inc (TSX:WLLW) (OTCQX:CANSF) announced Monday that it has successfully
  developed a scalable process for producing cannabigerol (CBG) with greater than
  99% purity and no detectable THC with demonstrated production at 500-litre scale.
  The Vancouver-based company previously ...


Willow Biosciences says it has successfully developed scalable process for producing CBG with greater than 99% purity and no detectable THC

---
- A drug product manufacturing facility in Albuquerque will be part of a global effort
  to deliver a vaccine to halt the spread of Covid-19 infections. Earlier this month,
  Albany Molecular Research Inc. announced it signed a supply agreement with AstraZeneca
  to support the manufacture of the pharmaceutical giant's Covid-19 vaccine candidate
  known as AZD1222, according to an AMRI news release.


ABQ plant to play a role in production of Covid-19 vaccine candidate for AstraZeneca

---
- Willow Biosciences Inc (TSX:WLLW) (OTCQX:CANSF) CEO Trevor Peters told shareholders
  on Wednesday that the biotechnology company has made good progress towards commercialization,
  and expedited its pilot phase for its portfolio of cannabinoids. In a statement
  accompanying the Calgary, Alberta-...


Willow Biosciences CEO says firm makes better-than-expected progress towards commercialization as it posts 2Q results

---
- Willow Biosciences Inc (TSX:WLLW) (OTCQX:CANSF) is getting ready to become the first
  company to biosynthetically produce non-psychoactive cannabinoids as it begins a
  pilot production run of cannabigerol, or CBG. The biotechnology company commenced
  a 500-litre production run to deliver samples of CBG...


Willow Biosciences kicks off pilot production run of high-purity CBG, a non-psychoactive cannabinoid compound

---
- COLUMBUS, Ohio, Jan. 17, 2019 /PRNewswire/ -- CAS, a division of the American Chemical
  Society (ACS), announced today that AMRI, a leading global life sciences contract
  research, development and manufacturing organization with locations in North America,
  Europe and Asia, signed a 5-year agreement for SciFinder®.
- SciFinder gives AMRI's research team unlimited access to the most comprehensive
  collection of scientific content, expertly curated by CAS scientists, and powerful
  search functionality that helps them translate that information into innovative
  approaches.
- SciFinder is used by innovators across commercial, academic, and government organizations
  around the globe to gain insight from the published scientific literature including
  journals, patents, chemical substances, reactions, properties and more.
- CAS, a division of the American Chemical Society, partners with R&D organizations
  globally to provide actionable scientific insights that help them plan, innovate,
  protect their innovations, and predict how new markets and opportunities will evolve.
- With locations in North America, Europe and Asia, AMRI's team combines scientific
  expertise and market-leading technology to provide a complete suite of solutions
  in Discovery, Development, Analytical Services, API Manufacturing and Drug Product.


Leading Global CRO/CDMO AMRI Commits to 5-year Agreement for SciFinder from CAS to Enable Efficient Research and Client Success

Provides chemistry research and drug development services and manufactures pharmaceutical preparations

Watchers	171
52-Wk Low	$13.01
52-Wk High	$22.17

Market Cap	$934.02M
Volume (M)	531,221.00
52-Wk High	$22.17
52-Wk Low	$13.01

AMRI Albany Molecular Research Inc.

About

Feed

News

Fundamentals